Restart Life Sciences Corp. (HEAL.CX)
0.07
0.00 (0.00%)
CAD |
CNSX |
Aug 27, 16:00
Restart Life Sciences Gross Profit Margin (Quarterly) : -80.76% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -80.76% |
| December 31, 2025 | |
| September 30, 2025 | |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | 97.53% |
| June 30, 2023 | |
| March 31, 2023 |
| Date | Value |
|---|---|
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -42.56K% |
| September 30, 2020 | -28.13K% |
| June 30, 2020 | -2.98K% |
| March 31, 2020 | -724.6% |
| December 31, 2019 | -11.11% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Spectral Medical, Inc. | -186.3% |
| Resverlogix Corp. | -- |
| Theratechnologies, Inc. | -- |
| COSCIENS Biopharma, Inc. | 55.27% |
| Defence Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -149.1% |
| Return on Assets | -91.69% |
| Return on Invested Capital | -124.3% |
| Profit Margin (Quarterly) | -242.3% |
| Operating Margin (Quarterly) | -232.5% |
| Return on Net Operating Assets | -438.5% |